Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:00 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | BAKER BROS. ADVISORS LP | 69,359,359 9.99% | 4,441,758 (+6.84%) | View |
| 2023-02-14 2:55 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Rock Springs Capital Management LP | 31,224,485 5.34% | 25,638,864 (+459.02%) | View |
| 2023-02-13 5:48 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Vivo Capital IX LLC | 3,761,947 3.1% | -5,647,104 (-60.02%) | View |
| 2023-02-13 1:21 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | SUVRETTA CAPITAL MANAGEMENT LLC | 36,822,190 5.9% | -8,888,145 (-19.44%) | View |
| 2022-10-28 1:17 pm Unchanged | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 83,780,600 13.41% | 0 (Unchanged) | View |
| 2022-09-23 4:18 pm Unchanged | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 83,780,600 13.41% | 0 (Unchanged) | View |
| 2022-08-23 6:31 pm Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 83,780,600 14.32% | 1,507,790 (+1.83%) | View |
| 2022-06-14 10:21 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 82,272,810 14.07% | 5,480,185 (+7.14%) | View |
| 2022-06-09 08:00 am Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 76,792,625 13.129% | 1,792,625 (+2.39%) | View |
| 2022-05-26 5:29 pm Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 75,000,000 12.82% | 427,765 (+0.57%) | View |
| 2022-02-15 12:44 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Rock Springs Capital Management LP | 5,585,621 5.13% | 5,585,621 (New Position) | View |
| 2022-02-14 4:50 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Point72 Asset Management L.P. | 10,610,000 9.1% | 3,710,331 (+53.78%) | View |
| 2022-02-14 4:40 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Boxer Capital LLC | 4,082,576 3.6% | -6,226,674 (-60.40%) | View |
| 2022-02-14 4:16 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | BAKER BROS. ADVISORS LP | 64,917,601 9.99% | 25,285,672 (+63.80%) | View |
| 2022-02-14 08:50 am Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 74,572,235 13.7% | 18,072,235 (+31.99%) | View |
| 2022-02-14 06:19 am Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | CITADEL ADVISORS LLC | 20,081,572 3.7% | -10,848,814 (-35.07%) | View |
| 2022-02-11 5:26 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Vivo Capital IX LLC | 9,409,051 7.8% | 448,755 (+5.01%) | View |
| 2022-02-11 4:37 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | SUVRETTA CAPITAL MANAGEMENT LLC | 45,710,335 8.4% | 13,882,835 (+43.62%) | View |
| 2022-02-11 4:31 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | ORBIMED ADVISORS LLC | 6,063,345 5.59% | 1,544,989 (+34.19%) | View |
| 2021-12-02 2:31 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 56,500,000 10.38% | 56,500,000 (New Position) | View |